Parameters | Value for group | |||
---|---|---|---|---|
Control (n = 15) | Endemic Control (n = 10) | P. vivax (n = 75) | P. vivax-treated (n = 10) | |
Age [median(range)] | 27 (19–35) | 38 (21–49) | 37 (20–80) | 42 (21–50) |
Gender [n(%)] | ||||
Male | 10 (66.7) | 6 (60.0) | 57 (76.0) | 6 (60.0) |
Female | 5 (33.3) | 4 (40.0) | 18 (24.0) | 4 (40.0) |
Parasitaemia (parasites/mm3), [n = (%)] | ||||
≤500 | – | – | 34 (45.3) | – |
501–10,000 | – | – | 26 (34.7) | – |
10,001–100,000 | – | – | 8 (10.7) | – |
Without information | – | – | 7 (9.3) | – |
Nº of previous malaria episodes [n(%)] | ||||
First malaria | – | 3 (30.0) | 10 (13.3) | 1 (10.0) |
≤5 | – | 2 (20.0) | 24 (32) | 2 (20.0) |
>5 | – | 5 (50.0) | 33 (44.0) | 6 (60.0) |
Without information | 0 (0.0) | 8 (10.7) | 1 (10.0) | |
Symptoms [n(%)] | ||||
Fever | – | – | 66 (97.1) | – |
Headache | – | – | 66 (97.1) | – |
Myalgia | – | – | 61 (89.7) | – |
Chills | – | – | 60 (88.2) | – |
Sweating | – | – | 51 (75.0) | – |
Arthralgia | – | – | 49 (72.1) | – |
Nausea | – | – | 36 (52.9) | – |
Vomiting | – | – | 20 (29.4) | – |